| Auto-antibodies against type I IFNs in patients with life-threatening COVID-19. H Lab, NU Im Science. 2020 Sep 24:eabd4585. doi: 10.1126/science.abd4585, 2020 | 2594* | 2020 |
| Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science. 2020 Sep 24:eabd4570. doi: 10.1126/science.abd4570, 2020 | 2239* | 2020 |
| Combination antiretroviral therapy and the risk of myocardial infarction Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group New England Journal of Medicine 349 (21), 1993-2003, 2003 | 2123 | 2003 |
| Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics E Petersen, M Koopmans, U Go, DH Hamer, N Petrosillo, F Castelli, ... The Lancet infectious diseases 20 (9), e238-e244, 2020 | 1422 | 2020 |
| Towards tuberculosis elimination: an action framework for low-incidence countries K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ... European Respiratory Journal 45 (4), 928-952, 2015 | 880 | 2015 |
| Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: a single center study of 100 patients in Brescia, Italy P Toniati, S Piva, M Cattalini, E Garrafa, F Regola, F Castelli, ... Autoimmunity reviews 19 (7), 102568, 2020 | 866 | 2020 |
| Mapping the human genetic architecture of COVID-19 Writing group Writing group leaders Pathak Gita A. 6 Andrews Shea J. 7 Kanai ... Nature 600 (7889), 472-477, 2021 | 771 | 2021 |
| Correlates and predictors of adherence to highly active antiretroviral therapy: overview of published literature A Ammassari, MP Trotta, R Murri, F Castelli, P Narciso, P Noto, J Vecchiet, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 31, S123-S127, 2002 | 672 | 2002 |
| GeoSentinel surveillance of illness in returned travelers, 2007–2011 K Leder, J Torresi, MD Libman, JP Cramer, F Castelli, P Schlagenhauf, ... Annals of internal medicine 158 (6), 456-468, 2013 | 558 | 2013 |
| Drivers of migration: why do people move? F Castelli Journal of travel medicine 25 (1), tay040, 2018 | 539 | 2018 |
| Autoantibodies neutralizing type I IFNs are present in~ 4% of uninfected individuals over 70 years old and account for~ 20% of COVID-19 deaths P Bastard, A Gervais, T Le Voyer, J Rosain, Q Philippot, J Manry, ... Science immunology 6 (62), eabl4340, 2021 | 492 | 2021 |
| Knowledge, attitudes and practices in travel-related infectious diseases: the European airport survey K Van Herck, F Castelli, J Zuckerman, H Nothdurft, P Van Damme, ... Journal of travel medicine 11 (1), 3-8, 2004 | 486 | 2004 |
| Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial E Kyriazopoulou, G Poulakou, H Milionis, S Metallidis, G Adamis, ... Nature medicine 27 (10), 1752-1760, 2021 | 480 | 2021 |
| Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 … P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ... The Lancet 393 (10167), 143-155, 2019 | 418 | 2019 |
| Efficacy, safety, and tolerability of dolutegravir-rilpivirine for the maintenance of virological suppression in adults with HIV-1: phase 3, randomised, non-inferiority SWORD-1 … JM Llibre, CC Hung, C Brinson, F Castelli, PM Girard, LP Kahl, EA Blair, ... The Lancet 391 (10123), 839-849, 2018 | 408 | 2018 |
| Factors associated with surgical mortality and complications among patients with and without coronavirus disease 2019 (COVID-19) in Italy F Doglietto, M Vezzoli, F Gheza, GL Lussardi, M Domenicucci, ... JAMA surgery 155 (8), 691-702, 2020 | 393 | 2020 |
| Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes B Ledergerber The Lancet 364 (9428), 51-62, 2004 | 391 | 2004 |
| X-linked recessive TLR7 deficiency in~ 1% of men under 60 years old with life-threatening COVID-19 T Asano, B Boisson, F Onodi, D Matuozzo, M Moncada-Velez, ... Science immunology 6 (62), eabl4348, 2021 | 364 | 2021 |
| An immune-based biomarker signature is associated with mortality in COVID-19 patients MS Abers, OM Delmonte, EE Ricotta, J Fintzi, DL Fink, AAA de Jesus, ... JCI insight 6 (1), 2021 | 337 | 2021 |
| Management of patients on dialysis and with kidney transplantation during the SARS-CoV-2 (COVID-19) pandemic in Brescia, Italy F Alberici, E Delbarba, C Manenti, L Econimo, F Valerio, A Pola, C Maffei, ... Kidney International Reports 5 (5), 580-585, 2020 | 316 | 2020 |
